Senator Investment Group LP Decreased Acadia Pharmaceuticals (ACAD) Holding By $20.58 Million; Fil LTD Boosted Its United Parcel Service (UPS) Stake

January 12, 2018 - By Hazel Jackson

Senator Investment Group Lp decreased Acadia Pharmaceuticals Inc (ACAD) stake by 27.81% reported in 2017Q3 SEC filing. Senator Investment Group Lp sold 556,262 shares as Acadia Pharmaceuticals Inc (ACAD)’s stock declined 29.10%. The Senator Investment Group Lp holds 1.44 million shares with $54.39 million value, down from 2.00 million last quarter. Acadia Pharmaceuticals Inc now has $3.52 billion valuation. The stock increased 1.68% or $0.47 during the last trading session, reaching $28.37. About 1.62 million shares traded or 2.28% up from the average. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since January 12, 2017 and is downtrending. It has underperformed by 31.89% the S&P500.

Fil Ltd increased United Parcel Service Inc (UPS) stake by 4.56% reported in 2017Q3 SEC filing. Fil Ltd acquired 91,770 shares as United Parcel Service Inc (UPS)’s stock declined 3.26%. The Fil Ltd holds 2.10M shares with $252.59M value, up from 2.01M last quarter. United Parcel Service Inc now has $115.55B valuation. The stock increased 0.47% or $0.63 during the last trading session, reaching $134.09. About 4.20 million shares traded or 44.18% up from the average. United Parcel Service, Inc. (NYSE:UPS) has risen 2.10% since January 12, 2017 and is uptrending. It has underperformed by 14.60% the S&P500.

Since August 22, 2017, it had 0 insider purchases, and 1 sale for $2.02 million activity. $2.02 million worth of United Parcel Service, Inc. (NYSE:UPS) shares were sold by Gershenhorn Alan.

Among 21 analysts covering United Parcel Service (NYSE:UPS), 8 have Buy rating, 1 Sell and 12 Hold. Therefore 38% are positive. United Parcel Service had 55 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Wednesday, February 1 by BMO Capital Markets. The stock has “Buy” rating by Oppenheimer on Thursday, July 27. JP Morgan maintained it with “Neutral” rating and $114 target in Thursday, October 12 report. Zacks upgraded it to “Hold” rating and $110 target in Tuesday, September 1 report. The company was maintained on Wednesday, October 28 by Macquarie Research. Citigroup maintained United Parcel Service, Inc. (NYSE:UPS) rating on Friday, April 29. Citigroup has “Neutral” rating and $109 target. The stock has “Hold” rating by Robert W. Baird on Friday, September 29. The rating was maintained by BMO Capital Markets with “Market Perform” on Friday, October 27. The stock of United Parcel Service, Inc. (NYSE:UPS) earned “Hold” rating by BMO Capital Markets on Thursday, November 30. Loop Capital initiated the stock with “Hold” rating in Tuesday, December 20 report.

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.09, from 1.05 in 2017Q2. It increased, as 46 investors sold UPS shares while 390 reduced holdings. 104 funds opened positions while 395 raised stakes. 451.38 million shares or 0.77% more from 447.95 million shares in 2017Q2 were reported. Atria Investments Limited has invested 0.36% in United Parcel Service, Inc. (NYSE:UPS). Cibc World Mkts accumulated 110,830 shares. Estabrook Capital Management holds 0% or 250 shares. Parametric Portfolio Ltd owns 2.66 million shares or 0.36% of their US portfolio. Richard Bernstein Advsr Llc has invested 0.35% in United Parcel Service, Inc. (NYSE:UPS). Argi Inv Svcs Limited Liability Corporation has invested 0.12% in United Parcel Service, Inc. (NYSE:UPS). Gould Asset Mngmt Ltd Liability Company Ca holds 1,800 shares or 0.1% of its portfolio. The New York-based Miller Howard Investments has invested 1.28% in United Parcel Service, Inc. (NYSE:UPS). Community State Bank Na owns 16,468 shares. Vaughan Nelson Investment Mngmt Limited Partnership owns 10,000 shares. New England Research & reported 12,475 shares or 1.1% of all its holdings. Global X Mngmt Company Limited Liability Company owns 8,826 shares. The North Carolina-based Triangle Wealth has invested 0.12% in United Parcel Service, Inc. (NYSE:UPS). Usca Ria Ltd Liability accumulated 29,540 shares. Nexus Management Incorporated reported 7,450 shares.

Fil Ltd decreased Ishares Tr (AGG) stake by 59,838 shares to 1.32M valued at $144.69 million in 2017Q3. It also reduced Amgen Inc (NASDAQ:AMGN) stake by 143,891 shares and now owns 481,061 shares. Roper Technologies Inc (NYSE:ROP) was reduced too.

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on February, 27. They expect $-0.58 EPS, up 10.77% or $0.07 from last year’s $-0.65 per share. After $-0.53 actual EPS reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 9.43% negative EPS growth.

Investors sentiment decreased to 1.01 in 2017 Q3. Its down 0.04, from 1.05 in 2017Q2. It fall, as 25 investors sold ACAD shares while 58 reduced holdings. 32 funds opened positions while 52 raised stakes. 113.55 million shares or 1.98% less from 115.85 million shares in 2017Q2 were reported. Opus Point Prtn Management Limited Liability Corp reported 15,639 shares. Bb&T reported 0% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Tci Wealth Advsrs holds 0.03% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) or 1,600 shares. Paloma Mgmt Communications holds 0.01% or 18,200 shares. Oppenheimer Asset reported 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Eventide Asset Lc holds 334,700 shares or 0.71% of its portfolio. San Francisco Sentry Group (Ca) holds 0.06% or 4,427 shares in its portfolio. Tocqueville Asset Limited Partnership invested 0.02% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Creative Planning holds 47,811 shares or 0.01% of its portfolio. Price T Rowe Assocs Md has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Parametric Ltd Limited Liability Company accumulated 47,977 shares. Lpl Financial Lc holds 0.01% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 93,155 shares. Goldman Sachs Group holds 1.82 million shares or 0.02% of its portfolio. Riggs Asset Managment Communication holds 650 shares or 0.01% of its portfolio. Kistler stated it has 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

Among 12 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. ACADIA Pharmaceuticals had 33 analyst reports since August 7, 2015 according to SRatingsIntel. On Wednesday, November 8 the stock rating was maintained by J.P. Morgan with “Buy”. As per Friday, August 7, the company rating was maintained by Needham. The rating was maintained by Cowen & Co with “Outperform” on Sunday, August 9. The rating was upgraded by Piper Jaffray on Friday, January 22 to “Overweight”. On Wednesday, October 19 the stock rating was reinitiated by Roth Capital with “Neutral”. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) earned “Hold” rating by Vetr on Monday, August 10. Jefferies maintained it with “Buy” rating and $47.0 target in Monday, September 4 report. The firm has “Buy” rating given on Thursday, October 5 by J.P. Morgan. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Buy” rating given on Wednesday, August 9 by H.C. Wainwright. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Buy” rating given on Friday, September 4 by JP Morgan.

Since August 9, 2017, it had 0 insider buys, and 5 insider sales for $5.95 million activity. Baity Glenn sold $499,534 worth of stock. 25,000 shares were sold by Brege Laura, worth $751,543.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>